Persistent equine arteritis virus infection in HeLa cells

Journal of Virology

Volumn 82, Issue 17, 2008, Pages 8456-8464

  Zhang, Jianqiang ^a   Timoney, Peter J ^a   MacLachlan, N James ^b   McCollum, William H ^a   Balasuriya, Udeni B R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; E PROTEIN; GLYCINE; GP2 PROTEIN; GP3 PROTEIN; GP4 PROTEIN; GP5 PROTEIN; HISTIDINE; LEUCINE; NSP1 PROTEIN; NSP2 PROTEIN; NSP7 PROTEIN; NSP9 PROTEIN; PHENYLALANINE; PROLINE; SERINE; STRUCTURAL PROTEIN; THREONINE; TRYPTOPHAN; TYROSINE; VALINE; VIRUS PROTEIN; VIRUS RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EQUINE VIRAL ARTERITIS VIRUS; FEMALE; GENETIC ANALYSIS; GENOME; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN INTERACTION; SEQUENCE ANALYSIS; VIRUS CELL INTERACTION; VIRUS INFECTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ARTERITIS VIRUS, EQUINE; ARTERIVIRUS INFECTIONS; BASE SEQUENCE; CARRIER STATE; CYTOGENETIC ANALYSIS; ELECTROPORATION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HELA CELLS; HORSE DISEASES; HORSES; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; VIRAL NONSTRUCTURAL PROTEINS;

EQUIDAE; EQUINE ARTERITIS VIRUS;

EID: 50149110393     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01249-08     Document Type: Article

References (72)

1. Ahmed, R., W. M. Canning, R. S. Kauffman, A. H. Sharpe, J. V. Hallum, and B. N. Fields. 1981. Role of the host cell in persistent viral infection: revolution of L cells and reovirus during persistent infection. Cell 25:325-332.
2. Arbour, N., G. Cote, C. Lachance, M. Tardieu, N. R. Cashman, and P. J. Talbot. 1999. Acute and persistent infection of human neural cell lines by human coronavirus OC43. J. Virol. 73:3338-3350.
3. Arbour, N., S. Ekande, G. Cote, C. Lachance, F. Chagnon, M. Tardieu, N. R. Cashman, and P. J. Talbot. 1999. Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E. J. Virol. 73:3326-3337.
4. Balasuriya, U. B., J. F. Hedges, S. A. Nadler, W. H. McCollum, P. J. Timoney, and N. J. MacLachlan. 1999. Genetic stability of equine arteritis virus during horizontal and vertical transmission in an outbreak of equine viral arteritis. J. Gen. Virol. 80:1949-1958.
5. Balasuriya, U. B., J. F. Hedges, V. L. Smalley, A. Navarrette, W. H. McCollum, P. J. Timoney, E. J. Snijder, and N. J. MacLachlan. 2004. Genetic characterization of equine arteritis virus during persistent infection of stallions. J. Gen. Virol. 85:379-390.
6. Balasuriya, U. B., E. J. Snijder, H. W. Heidner, J. Zhang, J. C. Zevenhoven-Dobbe, J. D. Boone, W. H. McCollum, P. J. Timoney, and N. J. MacLachlan. 2007. Development and characterization of an infectious cDNA clone of the virulent Bucyrus strain of Equine arteritis virus. J. Gen. Virol. 88:918-924.
7. Balasuriya, U. B., E. J. Snijder, L. C. van Dinten, H. W. Heidner, W. D. Wilson, J. F. Hedges, P. J. Hullinger, and N. J. MacLachlan. 1999. Equine arteritis virus derived from an infectious cDNA clone is attenuated and genetically stable in infected stallions. Virology 260:201-208.
8. - cells. J. Gen. Virol. 65:915-924.
9. Benton, P. A., D. J. Barrett, R. L. Matts, and R. E. Lloyd. 1996. The outcome of poliovirus infections in K562 cells is cytolytic rather than persistent after hemin-induced differentiation. J. Virol. 70:5525-5532.
10. Borzakian, S., I. Pelletier, V. Calvez, and F. Colbere-Garapin. 1993. Precise missense and silent point mutations are fixed in the genomes of poliovirus mutants from persistently infected cells. J. Virol. 67:2914-2917.
11. Calvez, V., I. Pelletier, S. Borzakian, and F. Colbere-Garapin. 1993. Identification of a region of the poliovirus genome involved in persistent infection of HEp-2 cells. J. Virol. 67:4432-4435.
12. Cavanagh, D. 1997. Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch. Virol. 142:629-633.
13. Chan, P. K., K. F. To, A. W. Lo, J. L. Cheung, I. Chu, F. W. Au, J. H. Tong, J. S. Tam, J. J. Sung, and H. K. Ng. 2004. Persistent infection of SARS coronavirus in colonic cells in vitro. J. Med. Virol. 74:1-7.
14. Chen, L. K., C. L. Liao, C. G. Lin, S. C. Lai, C. I. Liu, S. H. Ma, Y. Y. Huang, and Y. L. Lin. 1996. Persistence of Japanese encephalitis virus is associated with abnormal expression of the nonstructural protein NS1 in host cells. Virology 217:220-229.
15. Chen, W., and R. S. Baric. 1995. Function of a 5′-end genomic RNA mutation that evolves during persistent mouse hepatitis virus infection in vitro. J. Virol. 69:7529-7540.
16. Chen, W., and R. S. Baric. 1996. Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence. J. Virol. 70:3947-3960.
17. Cifone, M. A., and I. J. Fidler. 1981. Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc. Natl. Acad. Sci. USA 78:6949-6952.
18. Colbere-Garapin, F., C. Christodoulou, R. Crainic, and I. Pelletier. 1989. Persistent poliovirus infection of human neuroblastoma cells. Proc. Natl. Acad. Sci. USA 86:7590-7594.
19. Couderc, T., N. Guedo, V. Calvez, I. Pelletier, J. Hogle, F. Colbere-Garapin, and B. Blondel. 1994. Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mice. J. Virol. 68:8386-8391.
20. Couderc, T., J. Hogle, H. Le Blay, F. Horaud, and B. Blondel. 1993. Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell. J. Virol. 67:3808-3817.
21. Crouch, E. C., K. R. Stone, M. Bloch, and R. W. McDivitt. 1987. Heterogeneity in the production of collagens and fibronectin by morphologically distinct clones of a human tumor cell line: evidence for intratumoral diversity in matrix protein biosynthesis. Cancer Res. 47:6086-6092.
22. de la Torre, J. C., E. Martinez-Salas, J. Diez, and E. Domingo. 1989. Extensive cell heterogeneity during persistent infection with foot-and-mouth disease virus. J. Virol. 63:59-63.
23. de la Torre, J. C., E. Martinez-Salas, J. Diez, A. Villaverde, F. Gebauer, E. Rocha, M. Davila, and E. Domingo. 1988. Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture. J. Virol. 62:2050-2058.
24. den Boon, J. A., E. J. Snijder, E. D. Chirnside, A. A. de Vries, M. C. Horzinek, and W. J. Spaan. 1991. Equine arteritis virus is not a togavirus but belongs to the coronaviruslike superfamily. J. Virol. 65:2910-2920.
25. Desforges, M., J. Charron, S. Berard, S. Beausoleil, D. F. Stojdl, G. Despars, B. Laverdiere, J. C. Bell, P. J. Talbot, C. P. Stanners, and L. Poliquin. 2001. Different host-cell shutoff strategies related to the matrix protein lead to persistence of vesicular stomatitis virus mutants on fibroblast cells. Virus Res. 76:87-102.
26. Diez, J., M. Davila, C. Escarmis, M. G. Mateu, J. Dominguez, J. J. Perez, E. Giralt, J. A. Melero, and E. Domingo. 1990. Unique amino acid substitutions in the capsid proteins of foot-and-mouth disease virus from a persistent infection in cell culture. J. Virol. 64:5519-5528.
27. Diez, J., M. Hofner, E. Domingo, and A. I. Donaldson. 1990. Foot-and-mouth disease virus strains isolated from persistently infected cell cultures are attenuated for mice and cattle. Virus Res. 18:3-7.
28. Dobbe, J. C., Y. van der Meer, W. J. Spaan, and E. J. Snijder. 2001. Construction of chimeric arteriviruses reveals that the ectodomain of the major glycoprotein is not the main determinant of equine arteritis virus tropism in cell culture. Virology 288:283-294.
29. Dryga, S. A., O. A. Dryga, and S. Schlesinger. 1997. Identification of mutations in a Sindbis virus variant able to establish persistent infection in BHK cells: the importance of a mutation in the nsP2 gene. Virology 228:74-83.
30. Duncan, G., I. Pelletier, and F. Colbere-Garapin. 1998. Two amino acid substitutions in the type 3 poliovirus capsid contribute to the establishment of persistent infection in HEp-2c cells by modifying virus-receptor interactions. Virology 241:14-29.
31. Gosselin, A. S., Y. Simonin, F. Guivel-Benhassine, V. Rincheval, J. L. Vayssiere, B. Mignotte, F. Colbere-Garapin, T. Couderc, and B. Blondel. 2003. Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells. J. Virol. 77:790-798.
32. Harnden, D. G., and H. P. Klinger (ed.) 1985. Birth defects: original article series, vol. 21, no. 1. ISCN (1985): an international system for human cytogenetics nomenclature. March of Dimes Birth Defects Foundation, New York, NY.
33. Hedges, J. F., U. B. Balasuriya, P. J. Timoney, W. H. McCollum, and N. J. MacLachlan. 1999. Genetic divergence with emergence of novel phenotypic variants of equine arteritis virus during persistent infection of stallions. J. Virol. 73:3672-3681.
34. Hedges, J. F., C. D. Demaula, B. D. Moore, B. E. McLaughlin, S. I. Simon, and N. J. MacLachlan. 2001. Characterization of equine E-selectin. Immunology 103:498-504.
35. Hofmann, M. A., R. Y. Chang, S. Ku, and D. A. Brian. 1993. Leader-mRNA junction sequences are unique for each subgenomic mRNA species in the bovine coronavirus and remain so throughout persistent infection. Virology 196:163-171.
36. Hofmann, M. A., S. D. Senanayake, and D. A. Brian. 1993. A translation-attenuating intraleader open reading frame is selected on coronavirus mRNAs during persistent infection. Proc. Natl. Acad. Sci. USA 90:11733-11737.
37. Hofmann, M. A., P. B. Sethna, and D. A. Brian. 1990. Bovine coronavirus mRNA replication continues throughout persistent infection in cell culture. J. Virol. 64:4108-4114.
38. Holyoak, G. R., T. V. Little, W. H. McCollam, and P. J. Timoney. 1993. Relationship between onset of puberty and establishment of persistent infection with equine arteritis virus in the experimentally infected colt. J. Comp. Pathol. 109:29-46.
39. Ingram, V. M., M. P. Ogren, C. L. Chatot, J. M. Gossels, and B. B. Owens. 1985. Diversity among Purkinje cells in the monkey cerebellum. Proc. Natl. Acad. Sci. USA 82:7131-7135.
40. Kaplan, G., A. Levy, and V. R. Racaniello. 1989. Isolation and characterization of HeLa cell lines blocked at different steps in the poliovirus life cycle. J. Virol. 63:43-51.
41. Lamontagne, L. M., and J. M. Dupuy. 1984. Persistent infection with mouse hepatitis virus 3 in mouse lymphoid cell lines. Infect. Immun. 44:716-723.
42. Lavi, E., A. Suzumura, M. Hirayama, M. K. Highkin, D. M. Dambach, D. H. Silberberg, and S. R. Weiss. 1987. Coronavirus mouse hepatitis virus (MHV)-A59 causes a persistent, productive infection in primary glial cell cultures. Microb. Pathog. 3:79-86.
43. Lichtner, R. B., P. S. Moskwa, and G. L. Nicolson. 1987. Heterogeneous expression of cytokeratins in metastatic mammary adenocarcinoma cells in vitro and in vivo. Invasion Metastasis 7:367-383.
44. Little, T. V., G. R. Holyoak, W. H. McCollum, and P. J. Timoney. 1991. Output of equine arteritis virus from persistently infected stallion is testosterone dependent, p. 225-229. In W. Plowright, P. D. Rossdale, and J. F. Wade (ed.), Proceedings of the 6th International Conference of Equine Infectious Diseases, Cambridge, United Kingdom.
45. MacLachlan, N. J., U. B. Balasuriya, J. F. Hedges, T. M. Schweidler, W. H. McCollum, P. J. Timoney, P. J. Hullinger, and J. F. Patton. 1998. Serologic response of horses to the structural proteins of equine arteritis virus. J. Vet. Diagn. Investig. 10:229-236.
46. McCollum, W. H., E. R. Doll, J. C. Wilson, and J. Cheatham. 1962. Isolation and propagation of equine arteritis virus in monolayer cell cultures of rabbit kidney. Cornell Vet. 52:452-458.
47. McCollum, W. H., T. V. Little, P. J. Timoney, and T. W. Swerczek. 1994. Resistance of castrated male horses to attempted establishment of the carrier state with equine arteritis virus. J. Comp. Pathol. 111:383-388.
48. McCollum, W. H., and P. J. Timoney. 1999. Experimental observation on the virulence of isolates of equine arteritis virus, p. 558-559. In U. Wernery, J. F. Wade, J. A. Mumford, and O. R. Kaaden (ed.), Proceedings of the 8th International Conference on Equine Infectious Diseases, Dubai, United Arab Emirates, 1998.
49. Mizutani, T., S. Fukushi, K. Ishii, Y. Sasaki, T. Kenri, M. Saijo, Y. Kanaji, K. Shirota, I. Kurane, and S. Morikawa. 2006. Mechanisms of establishment of persistent SARS-CoV-infected cells. Biochem. Biophys. Res. Commun. 347:261-265.
50. Moore, B. D., U. B. Balasuriya, J. F. Hedges, and N. J. MacLachlan. 2002. Growth characteristics of a highly virulent, a moderately virulent, and an avirulent strain of equine arteritis virus in primary equine endothelial cells are predictive of their virulence to horses. Virology 298:39-44.
51. Nicolson, G. L. 1987. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res. 47:1473-1487.
52. Okada, Y., G. Toda, H. Oka, A. Nomoto, and H. Yoshikura. 1987. Poliovirus infection of established human blood cell lines: relationship between the differentiation stage and susceptibility of cell killing. Virology 156:238-245.
53. Palacios, G., O. Jabado, N. Renwick, T. Briese, and W. I. Lipkin. 2005. Severe acute respiratory syndrome coronavirus persistence in Vero cells. Chin. Med. J. 118:451-459.
54. Pavio, N., M. H. Buc-Caron, and F. Colbere-Garapin. 1996. Persistent poliovirus infection of human fetal brain cells. J. Virol. 70:6395-6401.
55. Pavio, N., T. Couderc, S. Girard, J. Y. Sgro, B. Blondel, and F. Colbere-Garapin, 2000. Expression of mutated poliovirus receptors in human neuroblastoma cells persistently infected with poliovirus. Virology 274:331-342.
56. Pelletier, I., T. Couderc, S. Borzakian, E. Wyckoff, R. Crainic, E. Ehrenfeld, and F. Colbere-Garapin. 1991. Characterization of persistent poliovirus mutants selected in human neuroblastoma cells. Virology 180:729-737.
57. Pelletier, I., G. Duncan, and F. Colbere-Garapin. 1998. One amino acid change on the capsid surface of poliovirus sabin 1 allows the establishment of persistent infections in HEp-2c cell cultures. Virology 241:1-13.
58. Sawicki, S. G., J. H. Lu, and K. V. Holmes. 1995. Persistent infection of cultured cells with mouse hepatitis virus (MHV) results from the epigenetic expression of the MHV receptor. J. Virol. 69:5535-5543.
59. Schafer, D. A., J. B. Miller, and F. E. Stockdale. 1987. Cell diversification within the myogenic lineage: in vitro generation of two types of myoblasts from a single myogenic progenitor cell. Cell 48:659-670.
60. Snijder, E. J., and J. J. Meulenberg. 1998. The molecular biology of arteriviruses. J. Gen. Virol. 79:961-979.
61. Snijder, E. J., H. van Tol, K. W. Pedersen, M. J. Raamsman, and A. A. de Vries. 1999. Identification of a novel structural protein of arteriviruses. J. Virol. 73:6335-6345.
62. Stueckemann, J. A., M. Holth, W. J. Swart, K. Kowalchyk, M. S. Smith, A. J. Wolstenholme, W. A. Cafruny, and P. G. Plagemann. 1982. Replication of lactate dehydrogenase-elevating virus in macrophages. 2. Mechanism of persistent infection in mice and cell culture. J. Gen. Virol. 59:263-272.
63. Tijms, M. A., D. D. Nedialkova, J. C. Zevenhoven-Dobbe, A. E. Gorbalenya, and E. J. Snijder. 2007. Arterivirus subgenomic mRNA synthesis and virion biogenesis depend on the multifunctional nspl autoprotease. J. Virol. 81:10496-10505.
64. Timoney, P. J. 1988. Equine viral arteritis: epidemiology and control. J. Equine Vet. Sci. 8:54-59.
65. Timoney, P. J., and W. H. McCollum. 1993. Equine viral arteritis. Vet. Clin. N. Am. Equine Pract. 9:295-309.
66. Timoney, P. J., W. H. McCollum, and M. L. Vickers. 1997. The carrier stallion as a reservoir of equine arteritis virus. Equine Dis. Q. 6:2.
67. van Aken, D., J. Zevenhoven-Dobbe, A. E. Gorbalenya, and E. J. Snijder. 2006. Proteolytic maturation of replicase polyprotein pp1a by the nsp4 main proteinase is essential for equine arteritis virus replication and includes internal cleavage of nsp7. J. Gen. Virol. 87:3473-3482.
68. Wagner, H. M., U. B. Balasuriya, and N. James MacLachlan. 2003. The serologic response of horses to equine arteritis virus as determined by competitive enzyme-linked immunosorbent assays (c-ELISAs) to structural and non-structural viral proteins. Comp. Immunol. Microbiol. Infect. Dis. 26:251-260.
69. Yamate, M., M. Yamashita, T. Goto, S. Tsuji, Y. G. Li, J. Warachit, M. Yunoki, and K. Ikuta. 2005. Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus. Microbes Infect. 7:1530-1540.
70. Yunis, J. J. 1976. High resolution of human chromosomes. Science 191:1268-1270.
71. Zhang, J., Y. Y. Go, N. J. MacLachlan, B. J. Meade, P. J. Timoney, and U. B. R. Balasuriya. Amino acid substitutions in the structural or non-structural proteins of a vaccine strain of equine arteritis virus are associated with its attenuation. Virology, in press.
72. Ziebuhr, J., E. J. Snijder, and A. E. Gorbalenya. 2000. Virus-encoded proteinases and proteolytic processing in the Nidovirales. J. Gen. Virol. 81:853-879.